Abstract
Ehrlich ascites carcinoma induces hepatorenal injuries while acridine derivatives have antioxidant, anticancer, and anti-inflammatory. Thus, this study evaluated the protective potential of a newly synthesized the 9-diaminoacridine derivative (9-DAAD), N1-(acridin-9-yl) propane-1, 3-diamine hydrochloride, against Ehrlich ascites carcinoma (EAC) induced hepatorenal injury in female mice. Forty female mice were allocated into 4 groups. Group I was injected with 0.1% DMSO subcutaneously and kept a control. Group II received 9-DAAD (30 mg/kg bw/2 days) subcutaneously for 2 weeks. Group III was injected interaperitonealy with 2.5 × 106 cells of EAC/20 g bw. Group IV was injected with EAC as the third group and administered with 9-DAAD as the second group for 2 weeks after induction of EAC. EAC significantly elevated total leukocytes and platelets counts; activities of serum AST, ALT, and ALP; serum levels of alpha-fetoprotein; carcinoembryonic antigen; urea and creatinine; and expression of vascular endothelial growth factor protein in hepatic and renal tissues. Meanwhile it decreased red blood cells count, hemoglobin concentration and hematocrit value. At the same time, it significantly reduced serum levels of total protein and albumin and altered hepatic and renal tissues structures. Also, EAC decreased apoptosis and DNA synthesis in hepatic and renal cells. However, treatment of EAC-bearing mice with 9-DAAD improved liver and kidney structures, functions and modulated EAC altered parameters, as well as it reduced hepatic and renal cells proliferation and DNA synthesis. This study indicated that 9-DAAD had a potential ameliorative effect against EAC-induced hepatorenal injury.
Similar content being viewed by others
Data availability
All data used in this study are included in this published article
Abbreviations
- AFP:
-
Alpha-fetoprotein
- Alb:
-
albumin
- ALP:
-
Alkaline phosphatase
- ALT:
-
Alanine transaminase
- AST:
-
Aspertate transaminase
- CBC:
-
Complete blood count
- CEA:
-
Carcinoembryonic antigen
- Cv:
-
Central vein
- 9-DAAD:
-
N1-(acridin-9-yl) propane-1, 3-diamine hydrochloride
- EAC:
-
Ehrlich ascites carcinoma
- EST:
-
Ehrlich solid tumor
- G:
-
Glomeruli
- H&E:
-
Hemotoxylin and eosin
- Hb:
-
Hemoglobin
- Hct:
-
Hematocrit
- Hp:
-
Hepatocellular
- MCHC:
-
Mean corpuscular hemoglobin concentration
- MCV:
-
Mean corpuscular volume
- Plt:
-
Platelets
- RBCs:
-
Red blood cells
- ROS:
-
Reactive oxygen species
- Rt:
-
Renal tissue
- T. Protein:
-
Total protein
- VEGF:
-
Vascular endothelial growth factor
- WBCs:
-
White blood cells
References
Abd Eldaim MAA, Tousson E, El Sayed IET, El Aleim AEHA, Elsharkawy HN (2019) Grape seeds proanthocyanidin extract ameliorates Ehrlich solid tumor induced renal tissue and DNA damage in mice. Biomed Pharmacother 115:108908
Abd-Alhaseeb MM, Zaitone SA, Abou-El-Ela SH, Moustafa YMJPO (2014) Olmesartan potentiates the anti-angiogenic effect of sorafenib in mice bearing Ehrlich’s ascites carcinoma: role of angiotensin (1–7). PLoS One 9:e85891
Abdel-Daim MM, El-Sayed YS, Eldaim MA, Ibrahim A (2017) Nephroprotective efficacy of ceftriaxone against cisplatin-induced subchronic renal fibrosis in rats. Naunyn-Schmiedeberg’s Arch Pharmacol 390:301–309
Aldubayan MA, Elgharabawy RM, Ahmed AS, Tousson EJ (2019) Antineoplastic activity and curative role of avenanthramides against the growth of ehrlich solid tumors in mice. Oxid Med Cell Longev 2019:5162687
Alotaibi B, Tousson E, El-Masry TA, Altwaijry N, Saleh AJET (2020) Ehrlich ascites carcinoma as model for studying the cardiac protective effects of curcumin nanoparticles against cardiac damage in female mice. Environ Toxicol
Anand P, Kunnumakara AB, Sundaram C, Harikumar KB, Tharakan ST, Lai OS, Sung B, Aggarwal BB (2008) Cancer is a preventable disease that requires major lifestyle changes. Pharm Res 25:2097–2116
Bacherikov VA, Chang J-Y, Lin Y-W, Chen C-H, Pan W-Y, Dong H, Lee R-Z, Chou T-C, Su T-L (2005) Synthesis and antitumor activity of 5-(9-acridinylamino) anisidine derivatives. Bioorg Med Chem 13:6513–6520
Badr M, Edrees N, Abdallah A, El-Deen N, Neamat-Allah A, Ismail HJVI (2011) Anti-tumour effects of Egyptian propolis on Ehrlich ascites carcinoma. Vet Ital 47:341–350
Badr OM, Sakr S, Abd-Eltawab HJ (2016) Ameliorative effect of ginger extract against pathological alterations induced in mice bearing solid tumors. J Biosci App Res 2:185–196
Bancroft JD, Cook HC (1994) Manual of histological techniques and their diagnostic application. Churchill Livingstone, London
Belmont P, Dorange IJ (2008) Acridine/acridone: a simple scaffold with a wide range of application in oncology. Expert Opin Ther Pat 18:1211–1224
Belmont P, Bosson J, Godet T, Tiano MJC (2007) Acridine and Acridone Derivatives, Anticancer Properties and Synthetic Methods: Where Are We Now? Anti-Cancer Agents Med. 7:139–169
Bhattacharyya A, Mandal DP, Lahiry L, Bhattacharyya S, Chattopadhyay S, Ghosh UK, Sa G, Das TJ (2007) Black tea-induced amelioration of hepatic oxidative stress through antioxidative activity in EAC-bearing mice. J Environ Pathol Toxicol Oncol 26:245–254
Borentain P, Gerolami R, Dodero F, Chrestian M, Quillichini F, Ardissone J, Perrimond H, Chamlian A, Gerolami AJ (2006) High serum alkaline phosphatase level revealing a liver adenoma. Gastroenterol Clin Biol 30:304–306
Bowers LD, Wong ET (1980) Kinetic serum creatinine assays. II. A critical evaluation and review. Clin Chem 26:555–561
Bromberg N, Dreyfuss JL, Regatieri CV, Palladino MV, Duran N, Nader HB, Haun M, Justo GZ (2010) Growth inhibition and pro-apoptotic activity of violacein in Ehrlich ascites tumor. Chem Biol Interact 186:43–52
Bruce M, Bruden D, McMahon B, Christensen C, Homan C, Sullivan D, Deubner H, Williams J, Livingston S, Gretch DJ (2008) Clinical significance of elevated alpha-fetoprotein in Alaskan Native patients with chronic hepatitis C. J Viral Hepat 15:179–187
Carmeliet PJ (2005) VEGF as a key mediator of angiogenesis in cancer. Oncology 69:4–10
Chakraborty T, Bhuniya D, Chatterjee M, Rahaman M, Singha D, Chatterjee BN, Datta S, Rana A, Samanta K, Srivastawa SJ (2007) Acanthus ilicifolius plant extract prevents DNA alterations in a transplantable Ehrlich ascites carcinoma-bearing murine model. World J Gastroenterol 13:6538
Charmantray F, Martelli AJ (2001) Interest of acridine derivatives in the anticancer chemotherapy. Curr Pharm Des 7:1703–1724
Chen Y-L, Lu C-M, Chen I-L, Tsao L-T, Wang J-P (2002) Synthesis and antiinflammatory evaluation of 9-anilinoacridine and 9-phenoxyacridine derivatives. J Med Chem 45:4689–4694
Choi W-T, Kakar SJ (2017) Immunohistochemistry in the diagnosis of hepatocellular carcinoma. Gastroenterol Clin North Am 46:311–325
Cholewiński G, Dzierzbicka K, Kołodziejczyk AM (2011) Natural and synthetic acridines/acridones as antitumor agents: their biological activities and methods of synthesis. Pharmacol Rep 63:305–336
da Rocha Pitta MG, Souza ÉS, Barros FWA, Moraes Filho MO, Pessoa CO, Hernandes MZ, de Lima MC, Galdino SL, da Rocha Pitta I (2013) Synthesis and in vitro anticancer activity of novel thiazacridine derivatives. Med Chem Res 22:2421–2429
Dean PN, Jett JH (1974) Mathematical analysis of DNA distributions derived from flow microfluorometry. J Cell Biol 60:523–527
Demeunynck M (2004) Antitumour acridines. Univ Joseph Fourier 14:55–70
Denny WA (2002) Acridine derivatives as chemotherapeutic agents. Curr Med Chem 9:1655–1665
DeVita VT Jr, Lawrence T, Rosenberg SA (2012) Cancer: principles & practice of oncology: annual advances in oncology. Lippincott Williams & Wilkins, Philadelphia
Dickens BF, Weglicki WB, Boehme PA, Mak TI (2002) Antioxidant and lysosomotropic properties of acridine-propranolol: protection against oxidative endothelial cell injury. J Mol Cell Cardiol 34:129–137
Doumas BT, Watson WA, Biggs HG (1997) Albumin standards and the measurement of serum albumin with bromcresol green. Clin Chim Acta 258:21–30
El-Gebaly R, Aly A, Sallam A, Sarhan O, Eltohamy H (2010) Preventing of Ehrlich tumor metastasis in liver, kidney and spleen by electromagnetic field. Int J Phys Sci 5:2057–2065
El-Masry TA, Al-Shaalan NH, Tousson E, Buabeid M, Alyousef AM (2019) The therapeutic and antineoplastic effects of vitamin B17 against the growth of solid-form Ehrlich tumours and the associated changes in oxidative stress, DNA damage, apoptosis and proliferation in mice. Pak J Pharm Sci 32:2801–2810
El-Wahab A, Samia M, Fouda FM (2009) Histological and histochemical study on the effect of Ehrlich ascites carcinoma on the liver and kidney of mice and the possible protective role of tetrodotoxin. Egypt J Biol 11
Fenninger L, Mider G (1954) Advances in cancer research. Adv Cancer Res 2:229–253
Finney D (1971) Probit Analysis, 3” edition. Cambridge Univ. Press, Cambridge
Firdaws A, QadirSalihi A, Wasman N (2018): Effect of apricot kernel on some hematological, histological and biochemical parameters in CCl4-induced liver injury in rats. Al-Kitab J Pure Sci 2
Fujimoto K (1999) Principles of measurement in hematology analyzers manufactured by Sysmex Corporation. Sysmex J Int 9:31–44
Gamage SA, Tepsiri N, Wilairat P, Wojcik SJ, Figgitt DP, Ralph RK, Denny WA (1994) Synthesis and in vitro evaluation of 9-anilino-3, 6-diaminoacridines active against a multidrug-resistant strain of the malaria parasite Plasmodium falciparum. J Med Chem 37:1486–1494
Ghosh R, Bhowmik S, Guha D (2012) 9-Phenyl acridine exhibits antitumour activity by inducing apoptosis in A375 cells. Mol Cell Biochem 361:55–66
Goodell JR, Ougolkov AV, Hiasa H, Kaur H, Remmel R, Billadeau DD, Ferguson DM (2008) Acridine-based agents with topoisomerase II activity inhibit pancreatic cancer cell proliferation and induce apoptosis. J Med Chem 51:179–182
Gressner OA, Weiskirchen R, Gressner AM (2007) Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests. Clin Chim Acta 381:107–113
Guo F, Hu Y, Niu Q, Li Y, Ding Y, Ma R, Wang X, Li S, Xie J (2018) Grape seed proanthocyanidin extract inhibits human esophageal squamous cancerous cell line eca109 via the nf-κb signaling pathway. Mediators Inflamm 2018:1–12
Gupta M, Mazumder UK, Kumar RS, Sivakumar T, Vamsi ML (2004) Antitumor activity and antioxidant status of Caesalpinia bonducella against Ehrlich ascites carcinoma in Swiss albino mice. J Pharmacol Sci 94:177–184
Gupta N, Goswami B, Mittal PJ (2012) Effect of standard anthracycline based neoadjuvant chemotherapy on circulating levels of serum IL-6 in patients of locally advanced carcinoma breast–a prospective study. Int J Surg 10:638–640
Hashem M, Mohamed H, Magda S (2004) Clinicopathological, pathological and biophysical studies on the effect of electromagnetic field on the Ehrlich tumor cells implanted in mice. Egypt J Comp Clin Pathol 17:117–147
Hassanzadeh H, Bahrami AR, Sadeghian H, Rahimizadeh M, Matin M (2016) Cytotoxic and anticancer activities of an acridine derivative; 11-chloro-3-methyl-3H-imidazo [4, 5-a] acridine on 5637 cells. Med Chem Res 25:1852–1860
Hossain SU, Bhattacharya S (2007) Synthesis of O-prenylated and O-geranylated derivatives of 5-benzylidene2, 4-thiazolidinediones and evaluation of their free radical scavenging activity as well as effect on some phase II antioxidant/detoxifying enzymes. Bioorg Med Chem Lett 17:1149–1154
Huerta S, Goulet EJ, Huerta-Yepez S (2007) Screening and detection of apoptosis. J Surg Res 139:143–156
Hussein S (2003) Clinical biochemistry interpretation and applications First (Text Book)
Jang ES, Jeong S-H, Kim J-W, Choi YS, Leissner P, Brechot C (2016): Diagnostic performance of alpha-fetoprotein, protein induced by vitamin K absence, osteopontin, Dickkopf-1 and its combinations for hepatocellular carcinoma. PloS One 11
Kabel AM, Abdel-Rahman MN, El-Sisi AE-DE, Haleem MS, Ezzat NM, El Rashidy MA (2013) Effect of atorvastatin and methotrexate on solid Ehrlich tumor. Eur J Pharmacol 713:47–53
Kalirajan R, Muralidharan V, Jubie S, Gowramma B, Gomathy S, Sankar S, Elango K (2012) Synthesis of some novel pyrazole-substituted 9-anilinoacridine derivatives and evaluation for their antioxidant and cytotoxic activities. J Heterocycl Chem 49:748–754
Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24:2137–2150
King K, Cidlowski JJ (1998) Cell cycle regulation and apoptosis. Annu Rev Physiol 60:601–617
Kumar A, Srivastava K, Kumar SR, Puri S, Chauhan PM (2009) Synthesis of 9-anilinoacridine triazines as new class of hybrid antimalarial agents. Bioorg Med Chem Lett 19:6996–6999
Kumar R, Kaur M, Kumari MJAPP (2012) Acridine: a versatile heterocyclic nucleus. Acta Pol Pharm 69:3–9
Kuusela P, Haglund C, Roberts PJ (1991) Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases. Br J Cancer 63:636–640
Lewis SM, Bain BJ, Bates I, Dacie JV (2006) Dacie and Lewis practical haematology. Churchill livingstone
Lowry OH, Rosebrough NJ, Farr AL, Randall R (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Makhaeva GF, Lushchekina SV, Boltneva NP, Serebryakova OG, Rudakova EV, Ustyugov AA, Bachurin SO, Shchepochkin AV, Chupakhin ON, Charushin VN (2017) 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer’s disease treatment. Bioorg Med Chem Lett 25:5981–5994
Mangueira VM, Batista TM, Brito MT, de Sousa TKG, da Cruz RMD, de Abrantes RA, Veras RC, de Medeiros IA, de Paula Medeiros KK, da Costa Pereira ALJB (2017) A new acridine derivative induces cell cycle arrest and antiangiogenic effect on Ehrlich ascites carcinoma model. Biomed Pharmacother 90:253–261
Medhat D, Hussein J, El-Naggar ME, Attia MF, Anwar M, Latif YA, Booles HF, Morsy S, Farrag AR, Khalil WKJB (2017) Effect of Au-dextran NPs as anti-tumor agent against EAC and solid tumor in mice by biochemical evaluations and histopathological investigations. Biomed Pharmacother 91:1006–1016
Michel S, Gaslonde T, Tillequin F (2004) Benzo [b] acronycine derivatives: a novel class of antitumor agents. Eur J Med Chem 39:649–655
Mishra S, Tamta AK, Sarikhani M, Desingu PA, Kizkekra SM, Pandit AS, Kumar S, Khan D, Raghavan SC, Sundaresan N (2018) Subcutaneous Ehrlich ascites carcinoma mice model for studying cancer-induced cardiomyopathy. Sci Rep 8:1–11
Moss D, Henderson A, Tietz TJWSC, Philadelphia PA (1999) Textbook of Clinical Enzymology, Clinical Enzymology. p617-721
Mutar TF, Gazia MA, Salem SB, Hammed EH, Tousson E, Hepatology R (2019) Ehrlich ascites carcinoma bearing mice as model of human hepatocellular carcinoma. Asian J Res Rep Hepatol 1–9
Mutar TF, Tousson E, Hafez E, Abo Gazia M, Salem SBJET (2020) Ameliorative effects of vitamin B17 on the kidney against Ehrlich ascites carcinoma induced renal toxicity in mice. Environ Toxicol 35:528–537
Nadaraj V, Selvi ST, Mohan S (2009) Microwave-induced synthesis and anti-microbial activities of 7, 10, 11, 12-tetrahydrobenzo [c] acridin-8 (9H)-one derivatives. Eur J Med Chem 44:976–980
Nataru S, Pulicherla Y, Gaddala B (2014) A review on medicinal plants as a potential source for cancer. Int J Pharm Sci Rev Res 26:235–248
Oppegard LM, Ougolkov AV, Luchini DN, Schoon RA, Goodell JR, Kaur H, Billadeau DD, Ferguson DM, Hiasa H (2009) Novel acridine-based compounds that exhibit an anti-pancreatic cancer activity are catalytic inhibitors of human topoisomerase II. Eur J Pharmacol 602:223–229
Pamies RJ, Crawford DRJMC (1996) Tumor markers: an update. Med Clin North Am 80:185–199
Patt HM, Straube RL (1956) Measurement and nature of ascites tumor growth. Ann N Y Acad Sci 63:728–737
Patton C, Crouch SJAC (1977) Enzymatic colorimetric method to determine urea in serum. Anal. Chem 49:464–469
Picot J, Guerin CL, Le Van Kim C, Boulanger CMJC (2012) Flow cytometry: retrospective, fundamentals and recent instrumentation. Cytotechnology 64:109–130
Raghu PS (2018) Synthesis, charaterization and antioxidant activity of novel 9-(PIPERAZIN-1-YL) Acridine derivatives. World J Pharma Res 7:1739–1749
Recanatini M, Cavalli A, Belluti F, Piazzi L, Rampa A, Bisi A, Gobbi S, Valenti P, Andrisano V, Bartolini M (2000) SAR of 9-amino-1, 2, 3, 4-tetrahydroacridine-based acetylcholinesterase inhibitors: synthesis, enzyme inhibitory activity, QSAR, and structure-based CoMFA of tacrine analogues. J Med Chem 43:2007–2018
Richardson C, Yan S, Vestal CG (2015) Oxidative stress, bone marrow failure, and genome instability in hematopoietic stem cells. Int J Mol Sci 16:2366–2385
Ryan E, Blake AJ, Benoit A, David MF, Robert AK (2013) Efficacy of substituted 9-aminoacridine derivatives in small cell lung cancer. Invest New Drugs 31:285–292
Salem FS, Badr M, Neamat-Allah AJVI (2011) Biochemical and pathological studies on the effects of levamisole and chlorambucil on Ehrlich ascites carcinoma-bearing mice. Vet Ital 47:89–95
Santelli-Rouvier C, Barret J-M, Farrell CM, Sharples D, Hill BT, Barbe J (2004) Synthesis of 9-acridinyl sulfur derivatives: sulfides, sulfoxides and sulfones. Comparison of their activity on tumour cells. Eur J Med Chem 39:1029–1038
Schumann G, Klauke R (2003) New IFCC reference procedures for the determination of catalytic activity concentrations of five enzymes in serum: preliminary upper reference limits obtained in hospitalized subjects. Clin Chim Acta 327:69–79
Sharhan O, Heidelberg T, Hashim NM, Salman AA, Ali HM, Jayash SN (2018) Synthesis and biological study of acridine-based imidazolium salts. RSC Adv 8:38995–39004
Siegel R, DeSantis C, Jemal A (2014) Colorectal cancer statistics, 2014. CA Cancer J Clin 64:104–117
Somasagara RR, Hegde M, Chiruvella KK, Musini A, Choudhary B, Raghavan SC (2012) Extracts of strawberry fruits induce intrinsic pathway of apoptosis in breast cancer cells and inhibits tumor progression in mice. PLoS One 7:e47021
Sondhi S, Johar M, Singh N, Shukla R, Raghubir R, Dastidar SG (2002) Synthesis of sulpha drug acridine derivatives and their evaluation for anti-inflammatory, analgesic and anticancer activity. Indian J Chem –Sec B
Sondhi SM, Singh N, Lahoti AM, Bajaj K, Kumar A, Lozach O, Meijer LJB (2005) Synthesis of acridinyl-thiazolino derivatives and their evaluation for anti-inflammatory, analgesic and kinase inhibition activities. Bioorg Med Chem 13:4291–4299
Stillwell AP, Ho Y-H, Veitch C (2011) Systematic review of prognostic factors related to overall survival in patients with stage IV colorectal cancer and unresectable metastases. World J Surg 35:684–692
Takac P, Kello M, Vilkova M, Vaskova J, Michalkova R, Mojzisova G, Mojzis JJB (2020) Antiproliferative effect of acridine chalcone is mediated by induction of oxidative stress. Biomolecules 10:345
Tonelli M, Vettoretti G, Tasso B, Novelli F, Boido V, Sparatore F, Busonera B, Ouhtit A, Farci P, Blois S (2011) Acridine derivatives as anti-BVDV agents. Antiviral Res 91:133–141
Tousson E, Hafez E, Gazia MMA, Salem SB, Mutar TF (2020) Hepatic ameliorative role of vitamin B17 against Ehrlich ascites carcinoma–induced liver toxicity. Environ Sci Pollut Res Int 1–11
Tribukait B, Moberger G, Zetterberg A (1975) Pulse-cytophotometry, Part 1. 54:631–9
Van der Loos CM, Meijer-Jorna LB, Broekmans ME, Ploegmakers HP, Teeling P, de Boer OJ, van der Wal ACJ (2010) Anti-human vascular endothelial growth factor (VEGF) antibody selection for immunohistochemical staining of proliferating blood vessels. J Histochem Cytochem 58:109–118
Verma AK, Prasad SB (2012) Bioactive component, cantharidin from Mylabris cichorii and its antitumor activity against Ehrlich ascites carcinoma. Cell Biol Toxicol 28:133–147
Vindeløv LLJVAB (1977) Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions. Virchows Arch B Cell Pathol 24:227–242
Wainwright MJ (2001) Acridine—a neglected antibacterial chromophore. J Antimicrob Chemother 47:1–13
Wang W, Xu G, Jia W, Wang Z, Li J, Ma J, Ge Y, Xie S, Yu J (2009) Expression and correlation of hypoxia-inducible factor-1α, vascular endothelial growth factor and microvessel density in experimental rat hepatocarcinogenesis. J Int Med Res 37:417–425
Zaid OAA, Hassanein MR, EL-Senosi YA, EL-Shiekha M (2011) Biochemical effect of some antioxidant on metabolic changes in experimentally induced tumor in female mice. Benha Vet Med J 1:52–60
Author information
Authors and Affiliations
Contributions
Abd Eldaim MA and Tousson E suggested the idea and experimental design; Abd Elmaksoud, AZ and Ahmed A AS performed the experiment and wrote the draft of manuscript with the support of El Sayed IE and Tousson E; Abd Eldaim MA, Tousson E, and El Sayed IE supervised the implementation of the experiment and analyzed the results; Tousson E and Abd Elmaksoud AZ performed the histopathological examination. All authors discussed the results and contributed to finalize the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
All authors declared that they have no conflicts of interest regarding the publication of this manuscript
Ethical approval
Rearing, treatment of mice and all the experimental procedures were conducted in accordance with guide for animal use and approved by animal care and use committee (IACUC-SCI-TU- 0067), Faculty of Science, Tanta university, which followed the National Institutes of Health Guide for Care and Use of Laboratory Animals (Publication No. 85-23, revised 1985).
Additional information
Responsible editor: Mohamed M. Abdel-Daim
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Highlights
• Ehrlich ascites carcinoma (EAC) altered liver and kidney functions and structures.
• EAC elevated protein expression of tumor and angiogenesis biomarkers.
• EAC decreased apoptosis and DNA synthesis in hepatic and renal cells.
• 9-Diaminoacridine (9-DAAD) improved liver and kidney structures and functions.
• 9-DAAD reduced hepatic and renal cells proliferation and DNA synthesis.
Rights and permissions
About this article
Cite this article
Abd Eldaim, M.A., Tousson, E., El Sayed, I.E.T. et al. Ameliorative effects of 9-diaminoacridine derivative against Ehrlich ascites carcinoma–induced hepatorenal injury in mice. Environ Sci Pollut Res 28, 21835–21850 (2021). https://doi.org/10.1007/s11356-020-11857-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11356-020-11857-y